Cibiem Obtains $10,000,000 Series A Financing

  • Feed Type
  • Date
    10/18/2012
  • Company Name
    Cibiem
  • Mailing Address
    134 West 26th Street New York, NY 10001
  • Company Description
    Cibiem is a medical device company leveraging its proprietary, minimally invasive, catheter-based approach focused on Carotid Body Modulation (CBM) for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes and renal failure.
  • Website
    http://www.cibiem.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Cibiem is launching out of the medical device incubator Coridea, and will use the money to develop its catheter-based treatment of diseases such as hypertension, heart failure, diabetes and renal failure.
  • M&A Terms
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    Third Rock Ventures

By posting a comment, you agree to our terms and conditions.